The remainder of the everninomicin molecule is apparently derived principally from glucose. water was inoculated from a slant culture and grownfor 24 hours at 37°C. A 2.5% inoculum thus prepared was employed for 150 ml fermentation broth in 250 ml Erlenmeyer flasks. The flasks were covered with pads of non-absorbent cotton layered between cheese cloth. These pads were fixed to the flasks by clamps. Previous studies had shown that in 250 ml flasks the production of everninomicin complex per ml broth was identical in 150 ml as in 50 ml of fermentation medium, obviously due to sufficient air supply coming through the cotton pads and gauze.
The fermentation medium employed in these studies consisted of dextrose, 2.0 % ; Difco yeast extract, 0.5% ; calcium carbonate, 0.1% ; and tap water. The medium was adjusted to pH 7.2 with 0.5 N sodium hydroxide. The fermentation flasks were incubated at 28°C in a Gyrotory incubator shaker (model G25, New Brunswick Scientific Co., Inc., New Brunswick, N. J.) enabling the control of exhaust gases, particularly carbon dioxide, which was removed by gaseous flow through saturated barium hydroxide solution. Extraction, purification and separation of everninomicin complex : In all, 300ml broth was extracted three times with 300ml portions of methylene chloride ; the combined extracts were dried with anhydrous magnesium sulfate and concentrated under reduced pressure to approximately 30 ml when the crude everninomicin was precipitated by dropwise addition to 300ml of petroleum ether (b. p. 30~75°C). After several petroleum ether washings the crude precipitate was dried in vacuo. For the removal of impurities the crude dry complex mixture was dissolved in the minimum amount of upper phase of the solvent system : petroleum ether -1-butanol -acetone -water (1:1:1:1, v/v), adjusted to pH 8.0 by the addition of a ammonium hydroxide. The solution was chromatographed on a cellulose column, which was prepared with a slurry of Whatman CF ll cellulose in the lower phase of the solvent system. The elution of the everninomicin complex with the upper phase solvent was monitored by bioassay on agar plates (Difco Antibiotic Medium) seeded with Staphylococcus aureus (ATCC 5638 P). A final separation of the purified everninomicin complex was achieved by ascending thin-layer chromatography on fluorescent silica gel plates (Mallinckrodt Silicar TLC 7GF) of 40cm length. The thickness of the layer was 0.5 mm. The solvent system employed was benzene-acetone (3:2, v/v). Four major components were extracted from the chromatographic zones with methanol after their detection in ultraviolet light. The four components were designated as El, E2, E3 and E4, exhibiting in the above chromatographic system Rf values of 0.40, 0.32, 0.25 and 0.18, respectively. Component El seems to be identical with everninomicin D. It was the major component of the everninomicin complex.
Degradation of the everninomicins :
A degradation procedure similar to that for curamycin described by Galmarini and Deulofeu6) was carried out. Sufficient unlabelled carrier antibiotic was added to the radioactive separated components to produce a final weight of 6^8 mg of each component. The antibiotic components were dissolved in 0.5ml methanol to which 8ml of 0.1N hydrochloric acid was subsequently added, and the mixture was renuxed for 45 minutes. After cooling four extractions were made with 8ml portions of methylene chloride. After backwashing once with 4 ml of 0.1 N hydrochloric acid the pooled extracts were dried with anhydrous magnesium sulfate, and the methylenechloride solvent was removed by evaporation in vacuo. An aliquot of the residue was subjected to alkaline hydrolysis in 5ml 0.1 N sodium hydroxide for 12 hours at 37°C. After acidifying with 0.1 N hydrochloric acid to pH 2.0, four extractions were made with 8 ml portions of diethyl ether. The pooled diethyl ether extracts were dried with anhydrous magnesium sulfate, and the solvent was removed by evaporation in vacuo. A Zeisel degradation as described by Bentley and Lavate7) was run with an aliquot of the diethyl ether exract of component El after alkaline hydrolysis. The aqueous solutions remaining after the methylene chloride and diethyl ether extractions were used for the determination of the radioactivity of the residual carbohydrate moieties. Carbon-14 labelled precursors :
In this study five C-14 labelled precursors were employed. All were obtained from New England Nuclear Corporation. To obtain sterile dilute solutions the content of each ampoule was transferred into a screwcapped test-tube, the final volume adjusted to 10 ml with distilled water and the resultant solution autoclaved for 15 minutes at 121°C. A comparison of the incorporation at different points of the fermentation was made employing acetate-2-C-14, diethyl malonate-2-C-14, and D-glucose-uniformly labelled C-14. Two procedures were used for the addition of precursors : in procedure A, 20 juc per flask were added after 36 hours of fermentation ; procedure B, 5 julc were added after 48 hours, 10 juc after 72 hours, and 5 juc after 96 hours. The antibiotic mixture was isolated after 114 hours of fermentation.
Two precursors, methionine-methyl C-14 and malonic acid-2-C-14 were only used with procedure B. procedures. Someincorporation was also obtained from malonic acid. Acid and subsequent alkaline hydrolysis of the four everninomicins yielded according to chromatographic studies an identical aromatic moiety, comparable with the degradation product dichloroisoeverninic acid, obtained from a reference sample of everninomicin D. Acetate and diethyl malonate ester were principally incorporated into the dichloroisoeverninic acid moiey (Table 2) , whereas relatively poor incorporations were observed in the residual carbohydrate fractions. The methylene chloride extracts of the acid hydrolysates of the four everninomicins contained an aromatic moiety apparently identical by thin-layer chromatographic behavior to everninocin, an aromatic ester originally isolated from everninomicins D and B. The incorporation of radioactivity into this moiety was higher than that in the aromatic dichloroisoeverninic acid itself. The radioactivity from glucose in both procedures A and B is better incorporated into the carbohydrate portion of the everninomicin molecule than into the dichloroisoeverninic acid moiety. Nevertheless, incorporation of glucose into the aromatic acid was more efficient in procedure B than in procedure A.
Methionine was added to the fermentation broth according to procedure Another sugar found in everninomicin D is everninose which contains an O-methyl group2). Studies on mycarose, cladinose and desosamine16) showed the incorporation of the methyl group from methionine into C-methyl, O-methyl and N-methyl groups. Of special interest is observation of Corcoran17) that the total activity in cladinose as derived from methyl-labelled methionine was equally distributed between the C-methyl and Omethyl groups both on the C3 atom. The carbohydrate fractions of the everninomicins contained the major part of the incorporated glucose.
There was also some low activity from diethyl malonate and acetate in these fractions, which may be due to a resynthesis to glucose as proposed by Grisebach et al.18) The appearance of glucose in the aromatic acid can be expected as a result of dissimilations by the Embden-Meyerhof pathway leading to pyruvate and further to acetate. NO. 4 THE JOURNAL OF ANTIBIOTICS 215
